Taha Merghoub
机构：Cornell University, Swim Across America, Parker Institute for Cancer Immunotherapy, Weill Cornell Medicine · ORCID：0000-0002-1518-5111
发表论文 903 篇 · 总被引 55236 次 · h-index 94
代表论文
- Expert opinion on burning questions in cancer myeloid cell biology (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)
- Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models (2026 · The Journal of Experimental Medicine · 被引 1)
- Supplementary Figure 5 from Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy–Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones (2026)
- Supplementary Table 1 from Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy–Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones (2026)
- Supplementary Figure 2 from Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy–Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones (2026)
- Supplementary Figure 3 from Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy–Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones (2026)